You searched for "prostatic"
RSM (Royal Society of Medicine) Complexity and Complications: Navigating Advanced Prostate Cancer
This year’s RSM Cancer Day will focus on the evolving management of prostate cancer. With emerging evidence supporting radical prostatectomy in oligometastatic disease, the programme will examine patient selection, treatment strategies, and the latest advances for managing advanced-stage cases.Dundee Institute for Healthcare Simulation: Cadaveric HOLEP Masterclass
Join our course dedicated to Holmium enucleation of the prostate. This full immersion masterclass is intended for senior trainees (ST6>) focusing on a BPH interest and urology consultants to improve their HOLEP skills. Our expert faculty panel are from across the UK and the techniques taught are internationally recognized and affiliated.Urologists and oncologists needed - help improve active surveillance conversations
Targeting urologists and oncologists - for focus groups to be held after 31 July 2026 Do you support patients with low or intermediate-risk prostate cancer? Researchers from the University of Southampton are inviting urologists and oncologists to help refine an...EAU Masterclass on Focal therapy for localised prostate cancer
Focal Therapy (FT) is a promising treatment option aimed at improving the management of localised prostate cancer. This masterclass will provide you with an extensive review of the rationale for FT, the patient selection modalities and the available energy sources (HIFU, Cryo, IRE, Laser, Brachytherapy). Gain further knowledge and better understand the FT benefits.The value of Urolink: an OOPE experience
I was fortunate enough to be able to take some time out of my training after ST5 to pursue an Out Of Programme Experience (OOPE) year. During the Urolink meeting at the British Association of Urological Surgeons (BAUS) 2017 conference...Men with a susceptibility to prostate cancer: implications of family history in PCa risk-prediction
Incorporation of family history (FH) status into prostate cancer (PCa) risk stratification has the potential to underpin many aspects of PCa care. This group of men presents a unique challenge in early cancer detection, particularly given that most men without...
Factors and time to conversion from prostate cancer active surveillance to treatment
Active surveillance is the standard of care for men with low-risk and selected men with favourable intermediate risk prostate cancer. The aim is to reduce the morbidity and mortality of overtreatment of non-clinically significant prostate cancer. A significant proportion progress...Prostate Cancer UK Clinical Champions Programme
Prostate Cancer UK have opened applications for their award-winning Clinical Champions Programme.Can dogs smell prostate cancer?
For centuries we have known that man’s best friend has an exceptional sense of smell. ‘Sniffer’ dogs are found in a wide range of roles, including drug and explosive detection as part of airport security, helping emergency services locate survivors...Prostate cancer series: diagnostics 1
- Click here for Part 2 - A 58-year-old male is referred to your rapid access prostate clinic with a prostate specific antigen (PSA) of 6.0ng/ml. He has no lower urinary tract symptoms (LUTS), past medical history (PMH), or family...
